Aim: Visceral fat accumulation is known to underlie the clustering of cardiovascular risk factors. However, it is not completely understood how visceral fat accumulation influences the development of cardiovascular disease. In this study, we investigated the clinical impact of visceral adiposity on vascular stiffness and thickness in patients with type 2 diabetes (T2D). Methods: One hundred and sixty-one patients with T2D, including 92 men and 69 women, were included in this cross-sectional study. Visceral fat area (VFA) and subcutaneous fat area (SFA) were measured by dual bioelectrical impedance analysis. Stiffness parameter and intima-media thickness (IMT) of the common carotid artery were measured by ultrasonography. Results: The mean age and duration of diabetes in the study population were 61 years and 13.9 years, respectively. In men, VFA and waist circumference (WC) were positively correlated with stiffness parameter , whereas body mass index (BMI), WC, and SFA were negatively correlated with IMT. In contrast, in women, none of the obesity-related indices were significantly correlated with stiffness parameter or IMT. In multiple regression analyses, VFA as well as WC, BMI, and SFA were independently associated with stiffness parameter after adjustment for age and other potential confounders in men but not in women. None of the obesity-related indices were independently associated with IMT for either sex.
Introduction
Visceral obesity, which is a key component of the metabolic syndrome, underlies the clustering of cardiovascular risk factors including hypertension, dyslipidemia, and glucose intolerance 1) and is related to the risk of cardiovascular morbidity and mortality 2) . Visceral fat accumulation was also shown to be indepen-dently associated with the incidence of coronary artery diseases in several population-based studies 3, 4) . Moreover, several studies showed that the presence of metabolic syndrome was associated with the risk of cardiovascular morbidity and mortality even in subjects with type 2 diabetes (T2D) 5, 6) , indicating an important role for visceral adiposity in the development and progression of atherosclerotic cardiovascular disease (CVD) in such patients.
Alterations in vascular morphology and function can be assessed by ultrasonography as intima-media thickness (IMT) ("atherosclerosis") and vascular wall stiffness ("arteriosclerosis"), respectively 7) , both of which are shown to predict adverse CVD events [8] [9] [10] . Importantly, carotid arterial stiffness predicts CVD Copyright©2016 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.
protocol (No. 164).

Physical and Laboratory Measurements
Blood pressure was determined by the conventional cuff method with an automatic sphygmomanometer after subjects had rested for at least 15 min. WC was measured to the nearest centimeter at the level of the umbilicus in a standing position at the end of gentle expiration. Blood was drawn after an overnight fast, and biochemical parameters were analyzed by a standard laboratory method as previously described 26) .
Measurement of VFA by Dual BIA VFA, along with subcutaneous fat area (SFA), was measured by a dual BIA instrument (HDS-2000, Omron Healthcare Co. Ltd., Kyoto, Japan) in the morning after an overnight fast. Dual BIA calculates the cross-sectional area of intra-abdominal fat at the level of the umbilicus based on two different impedance values, as described elsewhere in detail 22, 23) . A close correlation between VFA determined by dual BIA and that obtained by a CT scan was previously demonstrated 22, 23) .
Measurement of carotid IMT and stiffness parameter
by ultrasonography IMT and stiffness parameter of the common carotid artery were measured by an ultrasonic phaselocked echo-tracking system, which was equipped with a high-resolution real-time 13-MHz linear scanner (Prosound F75; Hitachi Aloka Medical, Ltd., Tokyo, Japan) as previously reported 13, 27) . In brief, IMT of bilateral carotid arteries was measured at the sites of the most advanced atherosclerotic lesions in longitudinal and transverse projections. The greatest IMT, including plaque, was utilized as a marker of atherosclerotic changes in the carotid arteries.
Stiffness parameter , an index of arterial wall stiffness, was calculated as ln (Ps/Pd) Dd/(Ds − Dd), where Ps and Pd are systolic and diastolic blood pressure and Ds and Dd are systolic and diastolic inner diameters of the carotid artery, respectively 12, 13) . The greater stiffness parameter between the left and right carotid arteries was utilized as a marker of arteriosclerotic changes. Those measurements were performed in the morning after an overnight fast and with a resting period of 15 min in a quiet room airconditioned at 25 throughout the year. The subjects were also refrained from smoking, alcohol, and beverages containing caffeine a few hours before measurement according to the recommendations of the international task force 28) . mortality independent of simultaneously measured carotid IMT 11) . Our research group previously reported that both IMT and stiffness parameter of the carotid artery were higher in T2D subjects than in non-diabetic subjects 12, 13) . Previous community-based studies showed that presence of the metabolic syndrome was an independent determinant of both carotid IMT and stiffness 14) . Visceral adiposity estimated by computed tomography (CT), magnetic resonance imaging (MRI), or waist-to-hip ratio was also shown to be related to IMT 15) and distensibility/stiffness [16] [17] [18] of the carotid artery in healthy or non-diabetic subjects. However, regarding the link between visceral adiposity and the risk of CVD, only a few studies have focused on the differential impacts of visceral adiposity on vascular thickness and stiffness in subjects with T2D [19] [20] [21] . Recently, the dual bioelectrical impedance analysis (dual BIA) instrument was developed for measuring visceral fat area (VFA), and its clinical utility in detecting severity of the metabolic syndrome and effectiveness of weight reduction therapy in obese patients has been confirmed in pilot studies 22, 23) . Apart from the study of Bouchi et al. 24) , which used aortic pulse wave velocity (PWV), no study has so far investigated the association between VFA estimated by dual BIA and surrogate markers of CVD.
Aim
In this study, we evaluated visceral adiposity using a dual BIA instrument and investigated the clinical impact of visceral adiposity on arterial wall thickness and stiffness in patients with T2D in a cross-sectional manner.
Methods
Subjects
We consecutively enrolled 161 subjects with T2D (92 men and 69 women) who were admitted to the Diabetes Center of the Osaka City University Hospital for the purpose of glycemic control, education, and/or evaluation of diabetic complications between February 2013 and September 2014. T2D was diagnosed based on the criteria of the American Diabetes Association 25) . Subjects with type 1 diabetes and other types of diabetes were excluded from this study. We also excluded subjects with waist circumference (WC) 130 cm because their VFA cannot be measured by a dual BIA instrument. In our analyses, a smoker was defined as a current smoker. All subjects provided written informed consent, and the ethical review board of our institution approved this study
Abdominal Adiposity and Carotid Arterial Stiffness and Thickness in the T2D Subjects
The mean VFAs estimated by dual BIA in men and women were 99.3 53.2 cm 2 and 88.7 45.3 cm 2 , respectively, without a significant difference between the sexes (Table 1) . Similarly, no significant difference in SFA was found between the sexes. In good agreement with a pilot study in obese patients 23) , VFA estimated by dual BIA was closely correlated with BMI (r 0.807, p 0.001) and WC (r 0.881, p 0.001) in subjects with T2D (Supplemental Table  1 ). Moreover, VFA by dual BIA showed significant correlation with metabolic parameters, such as plasma immunoreactive insulin levels (r 0.415, p 0.001) and triglycerides levels (r 0.331, p 0.001) in all subjects and with HDL cholesterol levels (r 0.483, p 0.001) and diastolic blood pressure (r 0.280, p 0.022) in women (Supplemental Table 1 ).
The mean value of carotid stiffness parameter in the total population was 11.6 (range, 2.5-34.9), and there was no significant difference between men and women. The mean carotid IMT for the total population was 1.05 mm (range, 0.37-2.41), without a significant difference between the sexes ( Table 1) .
Association of Visceral Adiposity with Carotid Stiffness and Thickness
We first examined the association of carotid stiffness or thickness with obesity-related indices, including BMI, WC, VFA, and SFA, and other risk factors for CVD by simple linear regression analyses separately in men and women. In men, stiffness parameter was positively correlated with WC and VFA but not with BMI or SFA ( Fig. 1 and Table 2 ). IMT was negatively correlated with BMI, WC, and SFA but not with VFA (Supplemental Fig. 1 and Table 2 ). In contrast, in women, none of the obesity-related indices were significantly correlated with stiffness parameter (Supplemental Fig. 2 ) or IMT (Supplemental Fig. 3 ) ( Table 2) .
Among the other known risk factors for CVD, including age, blood pressure, fasting glucose level, HbA1c level, serum creatinine level, triglycerides level, HDL cholesterol level, and LDL cholesterol level, age was significantly correlated with stiffness parameter and IMT in both men and women. In addition, an inverse correlation between HDL cholesterol level and stiffness parameter was found in women ( Table 2) . None of the other cardiometabolic risk factors were significantly associated with stiffness parameter or IMT in each sex, presumably because a large number of the subjects were receiving medications for hypertension, dyslipidemia, and diabetes.
Statistics
Data were expressed as number (%), mean standard deviation (SD), or median (interquartile range) as appropriate. For comparisons between men and women, the 2 -test, Student's t-test, or Wilcoxon rank-sum test was performed as appropriate. Simple and multiple linear regression analyses were performed to evaluate the relationship between stiffness parameter or IMT and various clinical parameters, including obesity-related indices [body mass index (BMI), WC, VFA, and SFA]. Skewed parameters, including plasma triglycerides levels, were logarithmically transformed before regression analyses. In multiple regression analyses, stiffness parameter or IMT was the dependent variable, and obesity-related indices (BMI, WC, VFA, or SFA), age, systolic blood pressure, glycated hemoglobin A1c (HbA1c) level, serum creatinine level, high-density lipoprotein (HDL) cholesterol level, low-density lipoprotein (LDL) cholesterol level, smoking status, presence of treatment with statins, and presence of treatment with angiotensin-receptor blockers or angiotensin-converting enzyme inhibitors (ARB/ACEI) were the independent variables. A p value of 0.05 was considered to indicate statistical significance. Statistical analyses were performed using the JMP ® 10 software (SAS Institute Inc., Cary, NC).
Results
Clinical Characteristics of the Subjects
The clinical characteristics of the total study population as well as men and women separately are shown in Table 1 . Twenty (12%) subjects with T2D were treated with dietary therapy alone; 119 (74%) with oral hypoglycemic agents, including 90 with dipeptidyl peptidase-4 inhibitors, 62 with sulfonylureas, 60 with biguanides, 22 with thiazolidinediones, 19 with -glucosidase inhibitors, 5 with insulin secretagogues (glinides); 22 (14%) with insulin alone; 26 (16%) with a combination of insulin and oral hypoglycemic agents; and 3 (2%) with glucagon-like peptide-1 analogs. The mean age and known duration of diabetes in the study population were 61 years and 13.9 years, respectively. There were significantly more male smokers than female smokers. Plasma HDL cholesterol levels were lower in men than in women. Age, duration of diabetes, BMI, WC, blood pressure, presence of treatment with statins or ARB/ACEI, renal function, glycemic control, and lipid profiles other than HDL cholesterol were not significantly different between men and women. including systolic blood pressure, HbA1c level, serum creatinine level, HDL cholesterol level, LDL cholesterol level, smoking status, and presence of treatment with statins and ARB/ACEI (Table 3) . Among all the variables, obesity-related indices, such as VFA ( 0.417, p 0.001), SFA ( 0.488, p 0.001), WC ( 0.527, p 0.001), and BMI ( 0.443, p 0.002), along with age, were independently and positively associated with stiffness parameter in men (Table 3) , whereas none of these obesity-related indices were found to be a determinant of IMT (Table 3) . In women, none of the obesity-related indices were independently associated with carotid stiffness parameter
Multivariate Analyses of the Determinants for Carotid Stiffness and Thickness
Age was correlated not only positively with carotid stiffness parameter and IMT but also negatively with obesity-related indices (BMI, r 0.387, p 0.001; WC, r 0.305, p 0.001; VFA, r 0.249, p 0.001; SFA, r 0.381, p 0.001), suggesting that the correlations of obesity-related indices with stiffness parameter and IMT were confounded at least by age. Therefore, multiple regression analyses were performed to identify independent associations of visceral adiposity with carotid stiffness and thickness after adjusting for age and other potential confounders, Values are standard regression coefficients determined by multiple regression analyses. In men or women, body mass index (BMI), waist circumferences (WC), visceral fat area (VFA), or subcutaneous fat area (SFA) was set as an independent variable after adjustment for age, systolic blood pressure, HbA1c level, serum creatinine level, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, smoking status, and presence of treatment with statins and ARB/ACEI. p 0.01.
estimated by dual BIA was closely associated with carotid stiffness parameter , but not with IMT, in men. Importantly, the association between VFA and carotid stiffness was independent of known CVD risk factors. Moreover, in women, visceral adiposity was associated with neither carotid stiffness parameter nor IMT. These findings indicate an important role of visceral fat accumulation in the pathogenesis of arteriosclerosis or functional changes in arteries in men with T2D. We did not find a significant association between visceral adiposity and IMT in our male population. This finding is in disagreement with previous studies showing a positive association of visceral adiposity with IMT 15, 20, [29] [30] [31] . There are at least two possible explanations for the conflicting results. First, the methods of estimating visceral fat mass were different. A number of studies using ultrasonography have associated visceral fat thickness with IMT 20, [29] [30] [31] , whereas a few studies using CT, the gold standard for quantifying visceral fat mass, have provided inconsistent results on the relationship between VFA and IMT 15, 21) . Although both visceral fat thickness measured by ultrasonography 32) and VFA measured by dual BIA 22, 23) are reportedly well correlated with VFA determined by CT, estimates of local fat thickness and the total crosssectional area of visceral fat may be differently related to clinical parameters. Second, there were large differences between the study populations. The subjects of the previous studies were healthy 15, 31) , mostly nondiabetic 29, 30) , or much younger patients with T2D than those included in our study 20) . In contrast, our study included subjects with T2D with a relatively higher age and a long duration of the disease. In this regard, Konishi et al. 21) did not find a significant relationship between VFA and IMT in patients with T2D whose mean age, duration of diabetes, and IMT were similar to those of our subjects.
Despite no significant association between VFA and IMT, this study clearly demonstrated a positive correlation between VFA and carotid stiffness parameter in men with T2D. The association between visceral adiposity and carotid arterial stiffness measured by ultrasonography has been demonstrated in healthy subjects 16) and the general population 17) . Presence of the metabolic syndrome 14) or high waist-to-hip ratio 18) was also associated with increased carotid arterial stiffness in non-diabetic women 18) and community-dwelling subjects 14) . There are few studies investigating the impact of visceral fat mass on carotid arterial stiffness in patients with T2D 19, 21) . Diamant et al. 19) showed that carotid stiffness expressed as the distensibility coefficient was inversely associated with VFA measured by MRI in 16 patients with uncomplicated T2D or IMT (Table 3) .
Association between Carotid Stiffness and Thickness in Men
Finally, to understand the reason why visceral adiposity is associated with carotid arterial stiffness differently from thickness in men with T2D, we examined the association between carotid stiffness parameter and IMT. We found no significant correlation between stiffness parameter and IMT in men (Fig. 2) . Then, we divided the men into four groups according to the median values of carotid stiffness parameter (9.8) and IMT (0.93 mm) and compared clinical parameters between the men with high IMT but low stiffness parameter ("IMT-advanced") and those with high stiffness parameter but low IMT ("stiffness-advanced"). As expected from the results of multivariate analyses, subjects in the stiffness-advanced group were much more obese with greater BMI, WC, VFA, and SFA than those in the IMT-advanced group (Supplemental Table 2 ). In contrast, the other parameters, including age, duration of diabetes, blood pressure, medications, glycemic control, and lipid profile, were similar between the groups (Supplemental Table 2 ).
Discussion
This study explored the relationship between visceral adiposity and carotid arterial stiffness and thickness in patients with T2D and demonstrated that VFA of our previous studies, correlation with clamp-measured insulin sensitivity index was higher in carotid stiffness parameter (r 0.393, p 0.002) 12) than in IMT (r 0.225, p 0.014) 36) . Because visceral adiposity evidently underlies insulin resistance 1) , it is conceivable that accumulated visceral fat predominantly affects carotid arterial stiffness over wall thickness, at least partly through impaired insulin sensitivity in T2D men. Nevertheless, several studies indicate possible implications of adipocytokines or inflammatory factors, such as adiponectin 21, 38) , leptin 42) , TNF- 21) , C-reactive protein 19) , and interleukin-6 19) , in carotid arterial stiffness in subjects with T2D. Further studies are needed to completely understand how visceral adiposity regulates arterial stiffness and differently impacts carotid stiffness and thickness in diabetic individuals.
In contrast to men, women exhibited no significant association between visceral adiposity and carotid arterial stiffness in this study. Sex hormone is one of the possible explanations. Arterial stiffness is known to be affected by age-related loss of estrogen action in women 43, 44) . Moreover, the detrimental impact of diabetes on aortic and carotid arterial stiffness was reported to be greater in women than in men 45) . However, vascular endothelial function and arterial stiffness could be fluctuated with a menstrual cycle in premenopausal women 46) . Because we performed vascular measurements without considering menstrual cycle, it is possible that we could not detect the association between visceral adiposity and stiffness parameter in women in this study.
We noticed that SFA and VFA were differently correlated with IMT in men, but not in women, in univariate regression, although this correlation disappeared after multivariate adjustment. Similarly, univariate models showed different association of SFA and VFA with stiffness parameter in men, but not in women, although both were independent explanatory factors for stiffness parameter in multivariate models. We do not know the importance of these univariate findings nor the precise mechanisms. However, these findings may be related to the differential roles of SFA and VFA on insulin resistance, abnormal cytokine profile 1) and arterial wall thickness [29] [30] [31] and stiffness 16, 47) , as shown in the previous studies, and also indicate a possible difference in the adiposity-artery relationship between the sexes.
This study provides a clinical evidence supporting the critical role of visceral adiposity in carotid arterial stiffness in patients with T2D. Compared with the precedent studies in T2D subjects 19, 21) , novel findings of this study are that visceral adiposity is strongly associated with stiffness as a functional property, rather but not in age-matched healthy controls. Konishi et al. 21) also demonstrated that VFA measured by CT was independently associated with carotid stiffness parameter in 151 patients with T2D but not in agematched non-diabetic controls. These studies indicate that a strong association between abdominal obesity or visceral adiposity and carotid arterial stiffness can be observed in a wide range of subjects from the general population to patients with T2D and that this association is stronger in subjects with T2D than in those without it.
Differential impact of cardiovascular risk factors on arterial stiffness and IMT were also observed in Japanese patients with T2D 21, 33, 34) . Consistent with our results, several studies reported that the association with obesity-related measures was different between arterial stiffness and IMT 21, 35) . In Japanese T2D patients, VFA was significantly associated with carotid stiffness parameter but not with carotid IMT 21) . Moreover, BMI was a strong determinant of aortic PWV, but not carotid IMT, in obese T2D patients in the U.S 35) . On the other hand, dyslipidemia 21, 33) and hyperglycemia 34, 35) , but not obesityrelated indices, were preferentially associated with carotid IMT in subjects with T2D. In addition, we found that only obesity-related indices were significantly different between the men with higher stiffness but lower IMT and the men with lower stiffness but higher IMT. These observations indicate a preferential association of obesity with arterial stiffness over arterial thickness in T2D. Because the correlation between IMT and stiffness index is relatively low 14) , we speculate the dominant role of obesity in arterial stiffening regardless of arterial wall thickness.
Insulin resistance may be one of the mechanisms linking visceral adiposity to arterial stiffness. Our research group has extensively investigated the association between insulin resistance and carotid arterial stiffness and thickness in patients with T2D 12, [36] [37] [38] [39] . We 12) and others 16, 40) showed that insuli n sensitivity evaluated by the euglycemic hyperinsulinemic clamp technique was inversely associated with arterial stiffness of the carotid 12, 40) and femoral 12, 16) arteries in healthy women 16) and subjects with T2D 12, 40) . Moreover, we found that improved carotid stiffness parameter was associated with increased clamp-measured insulin sensitivity after short-term exercise 39) and with the increase in adiponectin levels after treatment with an insulin sensitizer pioglitazone or metformin 38) in patients with T2D. On the other hand, only a few studies 36, 41) including ours 36) showed significant and inverse relationship between carotid IMT and insulin sensitivity as determined by the euglycemic hyperinsulinemic clamp in patients with T2D. In T2D subjects research laboratory of the Department of Metabolism,than with wall thickness as a morphological property, of the carotid artery and that the association is found only in men. Because both carotid IMT and arterial stiffness independently predict CVD events [8] [9] [10] , this study indicates that visceral adiposity regulates arterial stiffness, regardless of arterial thickness, to potentially modulate the risk of CVDs in patients with T2D. This study further proposes that VFA, which can be repeatedly assessed by the dual BIA instrument, is a potential marker for monitoring the effect of weightreducing therapy on vascular health in patients with obesity and diabetes.
This study has several limitations. First, because this was a cross-sectional study, a causal relationship between visceral fat accumulation and carotid arterial stiffness could not be confirmed. Second, our subjects were receiving anti-hypertensive drugs and statins, which could have affected arterial stiffness and the related atherosclerotic risk factors. To minimize the effect of such treatments, we adjusted for the presence of these therapies in the multivariate analyses. Third, because the subjects with T2D were hospitalized largely with inadequate glycemic control, the current results cannot be generalized. Fourth, non-diabetic controls were not used to compare the findings, and we could not confirm that carotid stiffness parameter was increased in subjects with T2D. In our previous study, we used the same procedure to confirm that carotid stiffness parameter was higher in T2D patients than in non-diabetic subjects 37) . Finally, visceral adiposity was evaluated not by CT, the goldstandard method, but by dual BIA. However, previous studies reported a good correlation between VFA values obtained by CT and dual BIA 22, 23) .
Conclusion
This study demonstrates that visceral adiposity is independently associated with stiffness parameter of the carotid artery in men with T2D. Our data may indicate that the accumulated visceral fat preferentially affects arterial stiffness, known as an independent predictor of CVD. Further studies are required to identify the factors linking visceral fat accumulation and arterial stiffening in diabetes. In addition, interventional studies are warranted to clarify whether reduction of visceral adiposity could reverse arterial stiffness, a functional change of the arterial wall, in patients with diabetes at a high risk of CVDs. 
